Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment.
Massimino M, Giangaspero F, Garrè ML, Genitori L, Perilongo G, Collini P, Riva D, Valentini L, Scarzello G, Poggi G, Spreafico F, Peretta P, Mascarin M, Modena P, Sozzi G, Bedini N, Biassoni V, Urgesi A, Balestrini MR, Finocchiaro G, Sandri A, Gandola L; AIEOP Neuro-Oncology Group. Massimino M, et al. Among authors: sandri a. Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1440-5. doi: 10.1016/j.ijrobp.2006.03.052. Int J Radiat Oncol Biol Phys. 2006. PMID: 16863927
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, Garrè ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S, Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P, Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G, Madon E; AIEOP Pediatric Neuro-Oncology Group. Massimino M, et al. Among authors: sandri a. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1336-45. doi: 10.1016/j.ijrobp.2003.08.030. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050308
Treatment with oral etoposide for childhood recurrent ependymomas.
Sandri A, Massimino M, Mastrodicasa L, Sardi N, Bertin D, Basso ME, Todisco L, Paglino A, Perilongo G, Genitori L, Valentini L, Ricardi U, Gandola L, Giangaspero F, Madon E. Sandri A, et al. J Pediatr Hematol Oncol. 2005 Sep;27(9):486-90. doi: 10.1097/01.mph.0000181430.71176.b7. J Pediatr Hematol Oncol. 2005. PMID: 16189442
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients.
Riccardi A, Mazzarella G, Cefalo G, Garrè ML, Massimino M, Barone C, Sandri A, Ridola V, Ruggiero A, Mastrangelo S, Lazzareschi I, Caldarelli M, Maira G, Madon E, Riccardi R. Riccardi A, et al. Among authors: sandri a. Cancer Chemother Pharmacol. 2003 Dec;52(6):459-64. doi: 10.1007/s00280-003-0677-x. Epub 2003 Sep 16. Cancer Chemother Pharmacol. 2003. PMID: 13680160 Clinical Trial.
Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R. Ruggiero A, et al. Among authors: sandri a. J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2. J Neurooncol. 2006. PMID: 16292488 Clinical Trial.
187 results